Randy J Wald

This inventor holds 4 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Astellas Pharma Gmbh, Medivation Prostate Therapeutics, Inc., Bend Research, Inc.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Randy J Wald. Retrieved from https://idiyas.com/inventor/randy-j-wald-1f2dk7hh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 9)

% Patents Active = 75.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

Medivation Prostate Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502357 - Formulations of enzalutamide (2025-12-23),

2. 12447128 - Formulations of enzalutamide (2025-10-21),

3. 11839689 - Formulations of enzalutamide (2023-12-12),

4. 9713594 - Methods for making pharmaceutical solid dosage forms of spray-dried dispersions (2017-07-25),

Title: Innovations by Randy J. Wald

Introduction

Randy J. Wald is an accomplished inventor based in Bend, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for enzalutamide. With a total of 4 patents to his name, Wald's work has had a notable impact on the treatment of hyperproliferative disorders.

Latest Patents

Wald's latest patents focus on formulations of enzalutamide. This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders. His innovative approach in this area has the potential to enhance therapeutic outcomes for patients.

Career Highlights

Throughout his career, Wald has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Astellas Pharma GmbH and Medivation Prostate Therapeutics, Inc. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Wald has collaborated with several professionals in his field, including Sanjay Konagurthu and Douglas Alan Lorenz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Randy J. Wald's contributions to the field of pharmaceuticals, particularly through his patents on enzalutamide formulations, highlight his role as a significant inventor. His work continues to influence the treatment of hyperproliferative disorders, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.